Stock Acquisition Rights for Directors Subject to Operating Profit Conditions
First written in FY2017-Q1. 2 of 16 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2024: 1 of 8 companies on the "Worse" side.
6 other companies' latest entry also says "Other".
- FY2026Update of exercised and unexercised stock acquisition rightsAnnual report
「End of previous consolidated fiscal year 56,000 Exercised 25,000 Remaining unexercised 31,000」
During the fiscal year, 25,000 shares underlying the Fourth Series stock acquisition rights were exercised, leaving 31,000 shares unexercised. - FY2026-H1Update of total outstanding shares, stated capital and other items following exercise of stock acquisition rightsAnnual report
「1 April 2025–30 September 2025 (Note) 8,500 6,867,000 7,161 1,101,515 7,161 643,795 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of outstanding shares by 8,500 and increased both stated capital and the capital reserve by ¥7.161 million. - FY2025Update of remaining stock acquisition rightsAnnual report
「End of previous consolidated fiscal year 67,500 Exercised 11,500 Remaining unexercised 56,000」
During the fiscal year, 11,500 shares underlying the Fourth Series stock acquisition rights were exercised, leaving 56,000 shares unexercised. - FY2024Update of remaining stock acquisition rightsAnnual report
「Exercised 16,100 Remaining unexercised 67,500」
During the fiscal year, 16,100 shares underlying the Fourth Series stock acquisition rights were exercised, leaving 67,500 shares unexercised. - FY2024-Q2Update of outstanding shares following exercise of stock acquisition rightsAnnual report
「1 July 2023–30 September 2023 (Note) 3,000 6,833,900 2,527 1,073,628 2,527 615,908 (Note) Increase due to the exercise of stock acquisition rights.」
During the quarter, the exercise of stock acquisition rights increased the total number of outstanding shares by 3,000 and increased both stated capital and the capital reserve by ¥2.527 million. - FY2023Update of remaining stock acquisition rightsAnnual report
「End of previous consolidated fiscal year 85,100 Exercised 1,500 Remaining unexercised 83,600」
During the fiscal year, 1,500 shares underlying the Fourth Series stock acquisition rights were exercised, leaving 83,600 shares unexercised. - FY2022Completion of Third Series exercise and update of Fourth Series balanceAnnual report
「End of previous consolidated fiscal year 225,000 95,500 Exercised 225,000 10,400 Remaining unexercised — 85,100」
All 225,000 remaining shares underlying the Third Series stock acquisition rights subject to operating profit conditions were exercised, reducing the unexercised balance to zero. Of the Fourth Series stock acquisition rights, 10,400 shares were exercised, leaving 85,100 shares unexercised. - FY2022-Q3Update of total outstanding shares, stated capital and other items following exercise of stock acquisition rightsAnnual report
「1 October 2021–31 December 2021 (Note) 10,400 6,604,400 8,762 989,625 8,762 531,905 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights from October to December 2021 increased the total number of outstanding shares by 10,400 and increased both stated capital and the capital reserve by ¥8.762 million. - FY2021Update of exercised and unexercised stock acquisition rightsAnnual report
「Exercised 95,000 4,000 Remaining unexercised 225,000 95,500」
The remaining unexercised Third and Fourth Series stock acquisition rights after exercise during the fiscal year have been updated to 225,000 shares and 95,500 shares, respectively. - FY2021-Q2Update of total outstanding shares, stated capital and other items following exercise of stock acquisition rightsAnnual report
「1 July 2020–30 September 2020 (Note) 95,000 6,590,000 33,867 977,493 33,867 519,773 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights from July to September 2020 increased the total number of outstanding shares by 95,000 and increased both stated capital and the capital reserve by ¥33.867 million. - FY2021-Q1Update of outstanding shares following exercise of stock acquisition rightsAnnual report
「The increase in common shares from the end of the first quarter accounting period through the date of filing was attributable to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights between 1 July and 14 August 2020 increased the total number of outstanding shares by 50,000 and increased both stated capital and the capital reserve by ¥17.825 million. - FY2020Update of exercised, forfeited and remaining stock acquisition rightsAnnual report
「The Third Series stock acquisition rights comprised 4,500 shares exercised, 25,000 shares forfeited, and 320,000 shares remaining unexercised. The Fourth Series comprised 4,500 shares exercised, 2,500 shares forfeited, and 99,500 shares remaining unexercised.」
The company has updated the annual exercise and forfeiture figures and the remaining unexercised balance for existing stock options, including stock acquisition rights subject to operating profit conditions. - FY2018AdvancedAnnual report
「(a) If operating profit exceeds ¥1,900 million: exercisable percentage: 30% (b) If operating profit exceeds ¥2,100 million: exercisable percentage: 60% (c) If operating profit exceeds ¥2,600 million: exercisable percentage: 100% Operating profit for the consolidated fiscal year was ¥2,610.461 million, up 70.6% year on year.」
Operating profit exceeded ¥2,600 million, meeting the condition for 100% exercise of the Third Series stock acquisition rights. The remaining unexercised Third Series stock acquisition rights were stated as covering 595,000 shares. - FY2017-Q3Update of outstanding shares and remaining stock acquisition rights following exerciseAnnual report
「The number of shares increased by 100,000 through the exercise of stock acquisition rights between 1 October 2016 and 31 December 2016. Third Series stock acquisition rights: 5,950 rights; Fourth Series stock acquisition rights: 1,175 rights.」
During the quarter, the number of outstanding shares increased by 100,000 through the exercise of stock acquisition rights. The number of Fourth Series stock acquisition rights was also stated as 1,175. - FY2017-Q2AdvancedAnnual report
「(Fourth Series of Stock Acquisition Rights) Number of stock acquisition rights (rights): 1,210 (Note 1); number of shares underlying the stock acquisition rights (shares): 121,000 (Note 1); exercise period: 30 September 2018 to 13 September 2026 (Note 3). Conditions for exercise: (1) The holder of the stock acquisition rights must remain a director, audit and supervisory board member, or employee of the company or one of its affiliated companies at the time of exercise.」
In addition to the Third Series of stock acquisition rights subject to operating profit conditions, the company issued 1,210 Fourth Series stock acquisition rights covering 121,000 shares. The exercise period for the Fourth Series is from 30 September 2018 to 13 September 2026, and includes employment-status requirements and other conditions. - FY2017-Q1First statedAnnual report
「The company will issue paid stock acquisition rights to its directors in order to further enhance their motivation and morale and strengthen their unity in pursuing the medium- to long-term expansion of the company’s performance and growth in corporate value. The exercise period for these stock acquisition rights will be from 1 July 2017 to 28 July 2023. (a) If operating profit exceeds ¥1,900 million: exercisable percentage: 30% (b) If operating profit exceeds ¥2,100 million: exercisable percentage: 60% (c) If operating profit exceeds ¥2,600 million: exercisable percentage: 100%」
The company introduced a program to issue a total of 5,950 paid stock acquisition rights covering 595,000 shares to 7 directors. Subject to consolidated operating profit in any fiscal year from the fiscal year ended March 2017 through the fiscal year ended March 2019, 30% will be exercisable if operating profit exceeds ¥1,900 million, 60% if it exceeds ¥2,100 million, and 100% if it exceeds ¥2,600 million.